Monoclonal antibodies were a key tool in the early pandemic response, but are now ineffective against new variants — putting immunocompromised patients at risk. Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.
Learn about your ad choices:
dovetail.prx.org/ad-choices
